BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31566014)

  • 1. 18th world congress of basic and clinical pharmacology: thought-provoking lectures on drug safety issues.
    Cavero I; Holzgrefe HH
    Expert Opin Drug Saf; 2019 Dec; 18(12):1145-1148. PubMed ID: 31566014
    [No Abstract]   [Full Text] [Related]  

  • 2. Conference report: pharmacogenomics in special populations at WCP2018.
    Suarez-Kurtz G; Aklillu E; Saito Y; Somogyi AA
    Br J Clin Pharmacol; 2019 Mar; 85(3):467-475. PubMed ID: 30537134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18
    Cavero I; Holzgrefe HH
    Expert Opin Drug Saf; 2020 Jan; 19(1):19-22. PubMed ID: 31739696
    [No Abstract]   [Full Text] [Related]  

  • 4. Organs-on-Chips in Clinical Pharmacology: Putting the Patient Into the Center of Treatment Selection and Drug Development.
    Peck RW; Hinojosa CD; Hamilton GA
    Clin Pharmacol Ther; 2020 Jan; 107(1):181-185. PubMed ID: 31758803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofunctional test batteries in safety pharmacology - Current and emerging considerations for the drug development process.
    Jackson SJ; Authier S; Brohmann H; Goody SMG; Jones D; Prior H; Rosch A; Traebert M; Tse K; Valentin JP; Milne A
    J Pharmacol Toxicol Methods; 2019; 100():106602. PubMed ID: 31238094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory safety pharmacology: a new safety paradigm to de-risk drug candidates prior to selection for regulatory science investigations.
    Cavero I
    Expert Opin Drug Saf; 2009 Nov; 8(6):627-47. PubMed ID: 19998526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tools to investigate and avoid drug-hypersensitivity in drug development.
    Corsini E; Casula M; Tragni E; Galbiati V; Pallardy M
    Expert Opin Drug Discov; 2018 May; 13(5):425-433. PubMed ID: 29405076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
    Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
    Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report of the 18th congress of the Japanese Society for Regenerative Medicine.
    Itaba N; Shiota G
    Regen Ther; 2020 Jun; 14():43-47. PubMed ID: 31988994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15
    Cavero I; Holzgrefe H
    J Pharmacol Toxicol Methods; 2017; 83():55-71. PubMed ID: 27659846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation.
    Cavero I; Guillon JM; Ballet V; Clements M; Gerbeau JF; Holzgrefe H
    J Pharmacol Toxicol Methods; 2016; 81():21-36. PubMed ID: 27233533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving towards better predictors of drug-induced Torsade de Pointes. 2-3 November 2005, Crystal City, Virginia, USA.
    Cavero I; Crumb W
    Expert Opin Drug Saf; 2006 Mar; 5(2):335-40. PubMed ID: 16503753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety pharmacology in the nonclinical assessment of new medicinal products: definition, place, interest and difficulties.
    Claude JR
    Fundam Clin Pharmacol; 2002 Apr; 16(2):75-8. PubMed ID: 12031059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Pharmacology Society: 5th annual meeting.
    Cavero I; Crumb W
    Expert Opin Drug Saf; 2006 Jan; 5(1):181-5. PubMed ID: 16370966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2012 Annual Meeting of the Safety Pharmacology Society: spotlight on targeted oncology medicines.
    Cavero I
    Expert Opin Drug Saf; 2013 Jul; 12(4):589-603. PubMed ID: 23668378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty.
    Cavero I
    Expert Opin Drug Saf; 2015 Jun; 14(6):999-1008. PubMed ID: 25872620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INSPIRE: A European training network to foster research and training in cardiovascular safety pharmacology.
    Guns PD; Guth BD; Braam S; Kosmidis G; Matsa E; Delaunois A; Gryshkova V; Bernasconi S; Knot HJ; Shemesh Y; Chen A; Markert M; Fernández MA; Lombardi D; Grandmont C; Cillero-Pastor B; Heeren RMA; Martinet W; Woolard J; Skinner M; Segers VFM; Franssen C; Van Craenenbroeck EM; Volders PGA; Pauwelyn T; Braeken D; Yanez P; Correll K; Yang X; Prior H; Kismihók G; De Meyer GRY; Valentin JP
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106889. PubMed ID: 32565326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental Pharmacology - Special Issues During Childhood and Adolescence.
    Allegaert K
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S10-S11. PubMed ID: 30453364
    [No Abstract]   [Full Text] [Related]  

  • 19. 2011 Annual Meeting of the Safety Pharmacology Society: an overview.
    Cavero I
    Expert Opin Drug Saf; 2012 Mar; 11(2):341-53. PubMed ID: 22339583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data Science in Clinical Pharmacology and Drug Development for Improving Health Outcomes in Patients.
    Peck RW; Shah P; Vamvakas S; van der Graaf PH
    Clin Pharmacol Ther; 2020 Apr; 107(4):683-686. PubMed ID: 32202650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.